4.53
price up icon9.69%   0.40
after-market Handel nachbörslich: 4.54 0.010 +0.22%
loading
Schlusskurs vom Vortag:
$4.13
Offen:
$4.24
24-Stunden-Volumen:
5.26M
Relative Volume:
0.60
Marktkapitalisierung:
$813.51M
Einnahmen:
-
Nettoeinkommen (Verlust:
$-26.86M
KGV:
-18.43
EPS:
-0.2458
Netto-Cashflow:
$-28.39M
1W Leistung:
+13.11%
1M Leistung:
-18.08%
6M Leistung:
+139.68%
1J Leistung:
+335.58%
1-Tages-Spanne:
Value
$4.20
$4.66
1-Wochen-Bereich:
Value
$4.02
$4.66
52-Wochen-Spanne:
Value
$0.9516
$6.14

Sellas Life Sciences Group Inc Stock (SLS) Company Profile

Name
Firmenname
Sellas Life Sciences Group Inc
Name
Telefon
(646) 200-5278
Name
Adresse
7 TIMES SQUARE, NEW YORK, NY
Name
Mitarbeiter
13
Name
Twitter
Name
Nächster Verdiensttermin
2026-03-19
Name
Neueste SEC-Einreichungen
Name
SLS's Discussions on Twitter

Compare SLS vs VRTX, REGN, ARGX, ALNY, INSM

Aktien Preis Marktkapitalisierung Umsatz Nettogewinn Free Cashflow ENV
SLS icon
SLS
Sellas Life Sciences Group Inc
4.53 741.68M 0 -26.86M -28.39M -0.2458
VRTX icon
VRTX
Vertex Pharmaceuticals Inc
434.30 111.45B 12.07B 3.95B 3.19B 15.33
REGN icon
REGN
Regeneron Pharmaceuticals Inc
763.04 80.54B 14.34B 4.50B 3.77B 41.56
ARGX icon
ARGX
Argen X Se Adr
748.25 46.32B 4.16B 1.29B 734.26M 19.58
ALNY icon
ALNY
Alnylam Pharmaceuticals Inc
330.34 42.29B 3.71B 313.75M 465.38M 2.2571
INSM icon
INSM
Insmed Inc
163.81 35.01B 606.42M -1.28B -997.58M -6.403

Sellas Life Sciences Group Inc Stock (SLS) Upgrades & Downgrades

Datum Aktion Analytiker Ratingänderung
2021-07-21 Eingeleitet Cantor Fitzgerald Overweight
2018-11-01 Eingeleitet Oppenheimer Outperform
2018-04-02 Eingeleitet H.C. Wainwright Buy
2018-03-19 Hochstufung Maxim Group Hold → Buy

Sellas Life Sciences Group Inc Aktie (SLS) Neueste Nachrichten

pulisher
02:03 AM

SELLAS Life Sciences Group Stock Jumps 9.5% - National Today

02:03 AM
pulisher
Apr 05, 2026

Stock Report: Will SELLAS Life Sciences Group Inc benefit from green energy policies2026 Review & Safe Swing Trade Setup Alerts - baoquankhu1.vn

Apr 05, 2026
pulisher
Apr 04, 2026

FRA:RXK3 PB Ratio: 9.04 — 66% Above Median - gurufocus.com

Apr 04, 2026
pulisher
Apr 03, 2026

SELLAS Life Sciences Group (SLS) price target increased by 26.83% to 8.84 - MSN

Apr 03, 2026
pulisher
Apr 03, 2026

Sellas Life Sciences draws significant retail buzz as traders eye REGAL phase 3 catalyst – SLS stock soars 15% - MSN

Apr 03, 2026
pulisher
Apr 03, 2026

SLS stock rallies ahead of AML trial readout — 'Pharma Bro' Martin Shkreli says he's still 'very bearish,' predicts drug will fail - MSN

Apr 03, 2026
pulisher
Apr 03, 2026

SELLAS Life Sciences (SLS) to present SLS009 data at AACR 2026 - MSN

Apr 03, 2026
pulisher
Apr 02, 2026

SLS Technical Analysis & Stock Price Forecast - Intellectia AI

Apr 02, 2026
pulisher
Mar 30, 2026

SELLAS Life Sciences Group Stock Price Drops 7.7% - National Today

Mar 30, 2026
pulisher
Mar 30, 2026

Gainers Report: Whats next for SELLAS Life Sciences Group Inc stock2026 Highlights & Low Risk Growth Stock Ideas - baoquankhu1.vn

Mar 30, 2026
pulisher
Mar 30, 2026

SELLAS Life Sciences Group (NASDAQ:SLS) Stock Price Down 7.7%Here's Why - MarketBeat

Mar 30, 2026
pulisher
Mar 30, 2026

SLS Forecast, Price Target & Analyst Ratings | SELLAS LIFE SCIENCES GROUP I (NASDAQ:SLS) - ChartMill

Mar 30, 2026
pulisher
Mar 29, 2026

Why SELLAS Life Sciences Group (SLS) Is Down 8.3% After US$150 Million ATM Offering News - simplywall.st

Mar 29, 2026
pulisher
Mar 29, 2026

SLS stock jumps overnight: ‘potent’ AML drug data ahead of cancer summit fuels fresh momentum - MSN

Mar 29, 2026
pulisher
Mar 28, 2026

Sellas Life Sciences Secures Shelf Registration to Bolster Financial Flexibility - timothysykes.com

Mar 28, 2026
pulisher
Mar 28, 2026

Wall Street Analysts Believe SELLAS Life Sciences Group, Inc. (SLS) Could Rally 63.58%: Here's is How to Trade - MSN

Mar 28, 2026
pulisher
Mar 28, 2026

A Look At SELLAS Life Sciences Group (SLS) Valuation After SLS009 Data And New Equity Offering Plans - simplywall.st

Mar 28, 2026
pulisher
Mar 27, 2026

SELLAS Life Sciences (SLS) to Present SLS009 Data at AACR 2026 - Insider Monkey

Mar 27, 2026
pulisher
Mar 27, 2026

MACD Signal: Is SELLAS Life Sciences Group Incs ROIC above industry average2026 Price Targets & Smart Investment Allocation Tips - baoquankhu1.vn

Mar 27, 2026
pulisher
Mar 27, 2026

Vanguard (SLS) files amendment showing 0% beneficial ownership (warrants disclosed) - Stock Titan

Mar 27, 2026
pulisher
Mar 26, 2026

5 Popular Penny Stocks on Robinhood to Buy - Insider Monkey

Mar 26, 2026
pulisher
Mar 26, 2026

All you need to know about SELLAS Life Sciences Group, Inc. (SLS) rating upgrade to buy - MSN

Mar 26, 2026
pulisher
Mar 26, 2026

All Essential Information Regarding SELLAS Life Sciences Group, Inc. (SLS) Rating Raised to Buy - Bitget

Mar 26, 2026
pulisher
Mar 26, 2026

All You Need to Know About SELLAS Life Sciences Group, Inc. (SLS) Rating Upgrade to Buy - Yahoo Finance

Mar 26, 2026
pulisher
Mar 25, 2026

SELLAS Life Sciences Group Inc (SLS) Stock News & Articles - 24/7 Wall St.

Mar 25, 2026
pulisher
Mar 25, 2026

SLS Stock Jumps After Merck's Tern Deal Sparks Buyout Buzz In Blood-Cancer Space: Retail Bets On This Big Pharma Suitor - Stocktwits

Mar 25, 2026
pulisher
Mar 24, 2026

SLS Eyes New Capital Streams with Securities Shelf Registration - StocksToTrade

Mar 24, 2026
pulisher
Mar 24, 2026

SELLAS Life Sciences Group (NASDAQ:SLS) Trading Down 8.5%Here's Why - MarketBeat

Mar 24, 2026
pulisher
Mar 24, 2026

SELLAS Stock Up 346% in a Year as Cancer Vaccine Trial Nears Its Final 8 Deaths - AOL.com

Mar 24, 2026
pulisher
Mar 23, 2026

Sellas Life Sciences: New Price Targets Signal Optimism Amid Clinical Progress - stockstotrade.com

Mar 23, 2026
pulisher
Mar 23, 2026

SELLAS Life Sciences Group (NASDAQ:SLS) Trading Up 12.9%Here's Why - MarketBeat

Mar 23, 2026
pulisher
Mar 23, 2026

Dagco Inc. Purchases Shares of 577,540 SELLAS Life Sciences Group, Inc. $SLS - marketbeat.com

Mar 23, 2026
pulisher
Mar 22, 2026

SELLAS Life Sciences Group, Inc.(NasdaqCM:SLS) added to S&P Biotechnology Select Industry Index - marketscreener.com

Mar 22, 2026
pulisher
Mar 22, 2026

Penny Stocks To ResearchMarch 22nd - MarketBeat

Mar 22, 2026
pulisher
Mar 22, 2026

Assessing SELLAS Life Sciences Group (SLS) Valuation After Its Sharp Recent Share Price Run - Yahoo Finance

Mar 22, 2026
pulisher
Mar 21, 2026

Penny Stocks To Watch NowMarch 21st - MarketBeat

Mar 21, 2026
pulisher
Mar 21, 2026

BUY Rating on SELLAS: Pivotal REGAL Phase 3 Progress, Expanding AML Pipeline, and Cash Runway into 2027 Support Upside Potential - TipRanks

Mar 21, 2026
pulisher
Mar 21, 2026

Investment Review: Whats the beta of SELLAS Life Sciences Group Inc stockMarket Performance Recap & High Return Trade Opportunity Guides - baoquankhu1.vn

Mar 21, 2026
pulisher
Mar 21, 2026

SELLAS Life Sciences’ AML Pipeline Adds Key Clinical Checkpoints For Investors - simplywall.st

Mar 21, 2026
pulisher
Mar 20, 2026

SELLAS Life Sciences Group, Inc.: Fundamental Analysis and Financial Ratings | | US81642T2096 - marketscreener.com

Mar 20, 2026
pulisher
Mar 20, 2026

Form S-3ASR Sellas Life Sciences Group Inc For: 20 March - Investing.com

Mar 20, 2026
pulisher
Mar 20, 2026

SELLAS (NASDAQ: SLS) registers shelf and $150M ATM with TD Cowen - Stock Titan

Mar 20, 2026
pulisher
Mar 20, 2026

SLS Stock In Focus As Alliance Global Sees 92% Upside Following AML Trial Updates - Stocktwits

Mar 20, 2026
pulisher
Mar 20, 2026

SELLAS Life Sciences Group (NASDAQ:SLS) Shares Gap Up on Earnings Beat - MarketBeat

Mar 20, 2026

Finanzdaten der Sellas Life Sciences Group Inc-Aktie (SLS)

Umsatz

loading

Nettogewinn

loading

Free Cashflow

loading

ENV

loading

Sellas Life Sciences Group Inc-Aktie (SLS) Insiderhandel

Insiderhandel Beziehung Datum Transaktion Kosten #Aktien Wert ($) #Aktien Gesamt
VAN NOSTRAND ROBERT L
Director
Jun 12 '25
Buy
1.48
10,000
14,800
20,400
Wasman Jane
Director
May 30 '25
Buy
1.69
20,000
33,800
30,400
Kalin Katherine Bach
Director
May 22 '25
Buy
1.80
20,000
36,000
41,000
$48.77
price down icon 0.87%
$27.88
price down icon 1.59%
$47.32
price down icon 2.57%
$91.28
price up icon 0.11%
ONC ONC
$302.49
price down icon 2.67%
$163.81
price up icon 0.85%
Kapitalisierung:     |  Volumen (24h):